MC-38 - Syngeneic Model
Rincon Bio performs MC-38 syngeneic models to test efficacy of immunotherapies. Please see below for additional information or to request a quote.
MC-38 Cell Line derived from C57BL6 murine colon adenocarcinoma cells.
Used as a syngeneic model. Implanted tumor cells create a model in which to test the efficacy of novel immunotherapies
Rincon Bio Growth Curve
Cell Line: MC-38
Mouse Strain: C57 BL6
From implant to stratification: N/A
Cells Implanted per Animal: 500k
WHY WORK WITH
When you work with Rincon Bio, rest assured that all cancer efficacy studies will be performed in the USA, at competitive prices
Most efficacy studies can be initiated within two business days.
We love our clients. We are easy to work with. And we develop a personal interest in our clients and their studies.